New Key Statistics Module, Z-Score and F-Score
OTCPK:CPMD Key Ratios
| Market Cap $ M | 1.70 |
| Enterprise Value $ M | 22.96 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 1.20 |
| Price/Free Cash Flow | 2.40 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -0.01 |
| Beneish M-Score | -6.65 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.64 |
| EV-to-EBITDA | -2.64 |
| PEG | -- |
| Shares Outstanding M | 708.69 |
| Net Margin (%) | -666.22 |
| Operating Margin % | -170.16 |
| Pre-tax Margin (%) | -666.22 |
| Quick Ratio | -- |
| Current Ratio | 0.04 |
| ROA % (ttm) | -129.86 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -11.43 |
| Dividend Yield % | -- |
| Altman Z-Score | -32.62 |
CPMD Number of Guru Trades
CPMD Volume of Guru Trades
Gurus Latest Trades with OTCPK:CPMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CPMD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cannapharmarx Inc Insider Transactions
No Available Data
News about OTCPK:CPMD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers